We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+9.65%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$2.48B
AUM Growth
+$17.8M
Cap. Flow
-$127M
Cap. Flow %
-5.1%
Top 10 Hldgs %
64.83%
Holding
157
New
15
Increased
31
Reduced
63
Closed
18

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$126M
2
ZTO icon
ZTO Express
ZTO
+$60.1M
3
TRU icon
TransUnion
TRU
+$15.2M
4
MBLY icon
Mobileye
MBLY
+$13.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$4.67M

Sector Composition

Rank Sector Weight
1 Technology 19.71%
2 Energy 16.06%
3 Consumer Discretionary 15.49%
4 Industrials 14.8%
5 Financials 14.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WVE icon
51
Wave Life Sciences
WVE
$1.2B
$3.7M 0.15%
600,155
-55,176
-8% -$276K
MSFT icon
52
Microsoft
MSFT
$3.76T
$3.61M 0.15%
8,589
-17,400
-67% -$7.04M
ZTS icon
53
Zoetis
ZTS
$30.9B
$3.38M 0.14%
+20,000
New +$3.75M
GPCR icon
54
Structure Therapeutics
GPCR
$3.82B
$3.3M 0.13%
77,093
ACIU icon
55
AC Immune
ACIU
$232M
$3.24M 0.13%
1,095,026
-420,559
-28% -$1.51M
OMGA
56
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$3.24M 0.13%
886,782
VEEV icon
57
Veeva Systems
VEEV
$38.1B
$3.15M 0.13%
13,614
-1,321
-9% -$285K
IMTX icon
58
Immatics
IMTX
$1.33B
$3.03M 0.12%
288,689
-24,885
-8% -$290K
MASS icon
59
908 Devices
MASS
$361M
$2.81M 0.11%
372,300
-409,571
-52% -$3.04M
TRMD icon
60
TORM
TRMD
$2.99B
$2.79M 0.11%
79,825
ARWR icon
61
Arrowhead Research
ARWR
$12.5B
$2.78M 0.11%
97,168
LBPH
62
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$2.74M 0.11%
127,048
LULU icon
63
lululemon athletica
LULU
$14.5B
$2.73M 0.11%
+7,000
New +$3.24M
ORCL icon
64
Oracle
ORCL
$435B
$2.73M 0.11%
21,762
-2,381
-10% -$273K
LRCX icon
65
Lam Research
LRCX
$383B
$2.63M 0.11%
27,050
-100,910
-79% -$8.88M
AMAT icon
66
Applied Materials
AMAT
$415B
$2.6M 0.1%
12,616
-2,239
-15% -$411K
MRNA icon
67
Moderna
MRNA
$23.9B
$2.51M 0.1%
23,573
-57,679
-71% -$5.81M
KROS icon
68
Keros Therapeutics
KROS
$212M
$2.3M 0.09%
34,715
-14,168
-29% -$840K
ADSK icon
69
Autodesk
ADSK
$54.1B
$2.02M 0.08%
+7,769
New +$1.97M
TKNO icon
70
Alpha Teknova
TKNO
$361M
$1.93M 0.08%
727,761
-8,779
-1% -$27.2K
CVAC
71
DELISTED
CureVac
CVAC
$1.9M 0.08%
626,684
+128,778
+26% +$452K
QTTB icon
72
Q32 Bio
QTTB
$466M
$1.87M 0.08%
+109,964
New +$1.52M
HCM icon
73
HUTCHMED
HCM
$2.18B
$1.85M 0.07%
110,366
-16,972
-13% -$258K
NXPI icon
74
NXP Semiconductors
NXPI
$58.9B
$1.7M 0.07%
6,866
-725
-10% -$167K
TECH icon
75
Bio-Techne
TECH
$11.2B
$1.61M 0.06%
+22,824
New +$1.63M

Similar funds

Platinum Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, Platinum Investment Management held 157 positions worth $2.48B, up 0.72% from $2.46B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Platinum Investment Management withdrew a net $127M in Q1 2024, closing 18 positions and reducing 63 holdings. Its most notable exit was Icosavax, Inc. Common Stock, an estimated $21.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Energy and Consumer Discretionary.

Against the trend, Platinum Investment Management opened a new position in CoStar Group worth $4.83M.

  • Platinum Investment Management's largest Q1 2024 buy was CoStar Group: 50,000 shares worth $4.83M.
  • Platinum Investment Management added most to Broadcom in Q1 2024, an estimated $126M increase.
  • Platinum Investment Management's biggest Q1 2024 reduction was Pinduoduo, cutting an estimated $92.2M.
  • Platinum Investment Management fully exited Icosavax, Inc. Common Stock in Q1 2024, selling an estimated $21.8M.
  • Platinum Investment Management's ten largest holdings make up 65% of its $2.48B portfolio in Q1 2024.
  • Platinum Investment Management opened 15 new positions and closed 18 in Q1 2024.
  • Platinum Investment Management's portfolio value rose 0.72% quarter-over-quarter to $2.48B.

Based on Platinum Investment Management's 13F filing for Q1 2024, filed 13 May 2024.